MiNK Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	34	37	88	149	-	-
Market Cap Growth	-	-58.11%	-40.99%	-	-	-
Enterprise Value	31	34	69	111	41	26
PE Ratio	-1.64	-1.64	-3.15	-4.95	-	-
PB Ratio	-2.05	-2.05	-219.74	6.29	-	-
P/FCF Ratio	-2.33	-2.33	-4.61	-11.43	-	-
P/OCF Ratio	-2.34	-2.34	-4.67	-11.65	-	-
EV/Sales Ratio	-	-	-	-	-	38.41
EV/EBITDA Ratio	-1.51	-1.51	-2.46	-3.99	-2.99	-1.19
EV/EBIT Ratio	-1.49	-1.49	-2.45	-3.98	-2.98	-1.19
EV/FCF Ratio	-2.12	-2.12	-3.59	-8.45	-4.88	-1.72
Debt / Equity Ratio	-	-	-	-	-0.81	-0.74
Debt / EBITDA Ratio	-	-	-	-	-3.19	-1.21
Debt / FCF Ratio	-	-	-	-	-5.20	-1.74
Quick Ratio	0.30	0.30	1.55	2.36	0.19	0.04
Current Ratio	0.32	0.32	1.61	2.41	0.29	0.12
Interest Coverage	-	-	-	-11.42	-5.65	-14.25
Return on Equity (ROE)	197.00%	197.00%	-299.70%	200.80%	36.00%	-
Return on Assets (ROA)	-220.60%	-220.60%	-98.20%	-134.90%	-553.80%	-
Return on Capital (ROIC)	126.95%	126.95%	7712.20%	-119.27%	137.29%	233.06%
Earnings Yield	-65.38%	-60.80%	-31.74%	-20.22%	-	-
FCF Yield	-46.10%	-42.87%	-21.68%	-8.75%	-	-
Buyback Yield / Dilution	-2.04%	-2.04%	-29.38%	-7.95%	-178.87%	-
Total Shareholder Return	-2.04%	-2.04%	-29.38%	-7.95%	-178.87%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).